BioFactors (Oxford, England) · 2019
Benefits of curcumin in brain disorders.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bhat Abid, Mahalakshmi Arehally M, Ray Bipul, Tuladhar Sunanda, Hediyal Tousif A, Manthiannem Esther, Padamati Jagadeeswari, Chandra Ramesh, Chidambaram Saravana B, Sakharkar Meena K
Аннотация
Curcumin is widely consumed in Asia either as turmeric directly or as one of the culinary ingredients in food recipes. The benefits of curcumin in different organ systems have been reported extensively in several neurological diseases and cancer. Curcumin has got its global recognition because of its strong antioxidant, anti-inflammatory, anti-cancer, and antimicrobial activities. Additionally, it is used in diabetes and arthritis as well as in hepatic, renal, and cardiovascular diseases. Recently, there is growing attention on usage of curcumin to prevent or delay the onset of neurodegenerative diseases. This review summarizes available data from several recent studies on curcumin in various neurological diseases such as Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Huntington's disease, Prions disease, stroke, Down's syndrome, autism, Amyotrophic lateral sclerosis, anxiety, depression, and aging. Recent advancements toward increasing the therapeutic efficacy of curcuma/curcumin formulation and the novel delivery strategies employed to overcome its minimal bioavailability and toxicity studies have also been discussed. This review also summarizes the ongoing clinical trials on curcumin for different neurodegenerative diseases and patent details of curcuma/curcumin in India.
Предметные рубрики MeSH
Alzheimer DiseaseAmyotrophic Lateral SclerosisAnimalsAnxietyAutistic DisorderBiological AvailabilityCurcumaCurcuminDementiaDepressionDrug Delivery SystemsGliomaHumansHuntington DiseaseMultiple SclerosisMuscular Atrophy, SpinalNeuroprotective AgentsParkinson DiseasePatents as TopicPrion DiseasesStroke